Literature DB >> 25988777

Pediatric hydrocephalus: systematic literature review and evidence-based guidelines. Part 1: Introduction and methodology.

Ann Marie Flannery1, Laura Mitchell2.   

Abstract

This clinical systematic review of and evidence-based guidelines for the treatment of pediatric hydrocephalus were developed by a physician volunteer task force. They are provided as an educational tool based on an assessment of current scientific and clinical information as well as accepted approaches to treatment. They are not intended to be a fixed protocol, because some patients may require more or less treatment. In Part 1, the authors introduce the reader to the complex topic of hydrocephalus and the lack of consensus on its appropriate treatment. The authors describe the development of the Pediatric Hydrocephalus Systematic Review and Evidence-Based Guidelines Task Force charged with reviewing the literature and recommending treatments for hydrocephalus, and they set out the basic methodology used throughout the specific topics covered in later chapters.

Entities:  

Keywords:  AANS = American Association of Neurological Surgeons; CNS = Congress of Neurological Surgeons; JGC = Joint Guidelines Committee; hydrocephalus; practice guidelines; systematic evidence review

Mesh:

Year:  2014        PMID: 25988777     DOI: 10.3171/2014.7.PEDS14321

Source DB:  PubMed          Journal:  J Neurosurg Pediatr        ISSN: 1933-0707            Impact factor:   2.375


  2 in total

1.  Implementing a digital real-time Hydrocephalus and Shunt Registry to evaluate contemporary pattern of care and surgical outcome in pediatric hydrocephalus.

Authors:  Hans Christoph Bock; Maximilian Kanzler; Ulrich-Wilhelm Thomale; Hans Christoph Ludwig
Journal:  Childs Nerv Syst       Date:  2017-11-09       Impact factor: 1.475

2.  A new surgical method of treatment spontaneous intracranial hemorrhage.

Authors:  Ning Du; Xinjun Wang; Xuyang Zhang; Jingwei Xie; Shaolong Zhou; Yuehui Wu; Yongkun Guo
Journal:  Transl Neurosci       Date:  2021-04-20       Impact factor: 1.757

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.